N. Hribernik, “The Role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study”, Radiol Oncol, vol. 58, no. 3, pp. 335–347, Sep. 2024.